Literature DB >> 21219655

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness.

Iris K Rüssel1, Wessel P Brouwer, Tjeerd Germans, Paul Knaapen, J Tim Marcus, Jolanda van der Velden, Marco J W Götte, Albert C van Rossum.   

Abstract

BACKGROUND: Increased left ventricular (LV) torsion has been observed in patients with manifest familial hypertrophic cardiomyopathy (HCM), and is thought to be caused by subendocardial dysfunction. We hypothesize that increased LV torsion is already present in healthy mutation carriers with normal wall thickness.
METHODS: Seventeen carriers with an LV wall thickness <10 mm, and seventeen age and gender matched controls had cardiovascular magnetic resonance (CMR) cine imaging and tissue tagging. LV volumes and mass were calculated from the cine images. LV torsion, torsion rate, endocardial circumferential strain and torsion-to-endocardial-circumferential-shortening (TECS) ratio, which reflects the transmural distribution in contractile function, were determined using tissue tagging.
RESULTS: LV volumes, mass and circumferential strain were comparable between groups, whereas LV ejection fraction, torsion and TECS-ratio were increased in carriers compared to controls (63 ± 3% vs. 60 ± 3%, p = 0.04, 10.1 ± 2.5° vs. 7.7 ± 1.2°, p = 0.001, and 0.52 ± 0.14°/% vs. 0.42 ± 0.10°/%, p = 0.02, respectively).
CONCLUSIONS: Carriers with normal wall thickness display increased LV torsion and TECS-ratio with respect to controls, which might be due to subendocardial myocardial dysfunction. As similar abnormalities are observed in patients with manifest HCM, the changes in healthy carriers may be target for clinical intervention to delay or prevent the onset of hypertrophy.

Entities:  

Mesh:

Year:  2011        PMID: 21219655      PMCID: PMC3025877          DOI: 10.1186/1532-429X-13-3

Source DB:  PubMed          Journal:  J Cardiovasc Magn Reson        ISSN: 1097-6647            Impact factor:   5.364


  41 in total

1.  Cardiac motion tracking using CINE harmonic phase (HARP) magnetic resonance imaging.

Authors:  N F Osman; W S Kerwin; E R McVeigh; J L Prince
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

2.  Cardiac rotation and relaxation after anterolateral myocardial infarction.

Authors:  E Nagel; M Stuber; M Lakatos; M B Scheidegger; P Boesiger; O M Hess
Journal:  Coron Artery Dis       Date:  2000-05       Impact factor: 1.439

3.  Steady-state free precession with myocardial tagging: CSPAMM in a single breathhold.

Authors:  Jaco J M Zwanenburg; Joost P A Kuijer; J Tim Marcus; Robert M Heethaar
Journal:  Magn Reson Med       Date:  2003-04       Impact factor: 4.668

4.  Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease.

Authors:  Sherif F Nagueh; Judy McFalls; Denise Meyer; Rita Hill; William A Zoghbi; James W Tam; Miguel A Quiñones; Robert Roberts; A J Marian
Journal:  Circulation       Date:  2003-07-14       Impact factor: 29.690

Review 5.  Left ventricular torsion: an expanding role in the analysis of myocardial dysfunction.

Authors:  Iris K Rüssel; Marco J W Götte; Jean G Bronzwaer; Paul Knaapen; Walter J Paulus; Albert C van Rossum
Journal:  JACC Cardiovasc Imaging       Date:  2009-05

6.  Cardiac systolic rotation and contraction before and after valve replacement for aortic stenosis: a myocardial tagging study using MR imaging.

Authors:  Joern J W Sandstede; Thorsten Johnson; Kerstin Harre; Meinrad Beer; Siegfried Hofmann; Thomas Pabst; Werner Kenn; Wolfram Voelker; Stefan Neubauer; Dietbert Hahn
Journal:  AJR Am J Roentgenol       Date:  2002-04       Impact factor: 3.959

7.  Cardiac rotation and relaxation in patients with aortic valve stenosis.

Authors:  E Nagel; M Stuber; B Burkhard; S E Fischer; M B Scheidegger; P Boesiger; O M Hess
Journal:  Eur Heart J       Date:  2000-04       Impact factor: 29.983

Review 8.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

9.  Transmural gradients of cardiac myofiber shortening in aortic valve stenosis patients using MRI tagging.

Authors:  A Van Der Toorn; P Barenbrug; G Snoep; F H Van Der Veen; T Delhaas; F W Prinzen; J Maessen; T Arts
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06-20       Impact factor: 4.733

10.  Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy.

Authors:  Roselie J Jongbloed; Carlo L Marcelis; Pieter A Doevendans; Judith M Schmeitz-Mulkens; Willem G Van Dockum; Joep P Geraedts; Hubert J Smeets
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

View more
  24 in total

1.  Elevated Ca2+ transients and increased myofibrillar power generation cause cardiac hypercontractility in a model of Noonan syndrome with multiple lentigines.

Authors:  Sarah A Clay; Timothy L Domeier; Laurin M Hanft; Kerry S McDonald; Maike Krenz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-27       Impact factor: 4.733

2.  Left ventricular remodeling and torsion dynamics in hypertensive patients.

Authors:  Matteo Cameli; Matteo Lisi; Francesca Maria Righini; Alberto Massoni; Sergio Mondillo
Journal:  Int J Cardiovasc Imaging       Date:  2012-04-27       Impact factor: 2.357

3.  A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.

Authors:  Eric M Green; Hiroko Wakimoto; Robert L Anderson; Marc J Evanchik; Joshua M Gorham; Brooke C Harrison; Marcus Henze; Raja Kawas; Johan D Oslob; Hector M Rodriguez; Yonghong Song; William Wan; Leslie A Leinwand; James A Spudich; Robert S McDowell; J G Seidman; Christine E Seidman
Journal:  Science       Date:  2016-02-05       Impact factor: 47.728

4.  Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy.

Authors:  Sarah R Clippinger; Paige E Cloonan; Lina Greenberg; Melanie Ernst; W Tom Stump; Michael J Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-19       Impact factor: 11.205

5.  Hypertrophic cardiomyopathy mutations in MYBPC3 dysregulate myosin.

Authors:  Christopher N Toepfer; Hiroko Wakimoto; Amanda C Garfinkel; Barbara McDonough; Dan Liao; Jianming Jiang; Angela C Tai; Joshua M Gorham; Ida G Lunde; Mingyue Lun; Thomas L Lynch; James W McNamara; Sakthivel Sadayappan; Charles S Redwood; Hugh C Watkins; Jonathan G Seidman; Christine E Seidman
Journal:  Sci Transl Med       Date:  2019-01-23       Impact factor: 17.956

6.  Off-resonance insensitive complementary SPAtial Modulation of Magnetization (ORI-CSPAMM) for quantification of left ventricular twist.

Authors:  Meral Reyhan; Yutaka Natsuaki; Daniel B Ennis
Journal:  J Magn Reson Imaging       Date:  2013-04-26       Impact factor: 4.813

Review 7.  Noninvasive imaging modalities and sudden cardiac arrest in the young: can they help distinguish subjects with a potentially life-threatening abnormality from normals?

Authors:  Beth Feller Printz
Journal:  Pediatr Cardiol       Date:  2012-02-14       Impact factor: 1.655

Review 8.  Evaluation of left ventricular function, rotation, twist and untwist in patients with hypertrophic cardiomyopathy.

Authors:  Xue-Wei He; Ze-Zhou Song
Journal:  Exp Clin Cardiol       Date:  2013

9.  Association of Cardiomyopathy With MYBPC3 D389V and MYBPC3Δ25bpIntronic Deletion in South Asian Descendants.

Authors:  Shiv Kumar Viswanathan; Megan J Puckelwartz; Ashish Mehta; Chrishan J A Ramachandra; Aravindakshan Jagadeesan; Regina Fritsche-Danielson; Ratan V Bhat; Philip Wong; Sangeetha Kandoi; Jennifer A Schwanekamp; Gina Kuffel; Lorenzo L Pesce; Michael J Zilliox; U Nalla B Durai; Rama Shanker Verma; Robert E Molokie; Domodhar P Suresh; Philip R Khoury; Annie Thomas; Thriveni Sanagala; Hak Chiaw Tang; Richard C Becker; Ralph Knöll; Winston Shim; Elizabeth M McNally; Sakthivel Sadayappan
Journal:  JAMA Cardiol       Date:  2018-06-01       Impact factor: 14.676

Review 10.  Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy.

Authors:  Richard J Marszalek; R John Solaro; Beata M Wolska
Journal:  Pflugers Arch       Date:  2018-10-29       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.